DUSA Pharmaceuticals, Inc. Merger Litigation (Nasdaq: DUSA)

Law Office of Brodsky & Smith, LLC Announces Investigation of DUSA Pharmaceuticals, Inc. 
 
BALA CYNWYD, November 8, 2012/PR Newswire/ –Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of DUSA Pharmaceuticals, Inc. (“DUSA” or the “Company”) (Nasdaq- DUSA-News) relating to the proposed acquisition by Sun Pharmaceutical Industries Ltd. (“Sun”).  
 
Under the terms of the transaction, DUSA shareholders will receive only $8.00 in cash for each share of DUSA stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of DUSA for not acting in the Company’s shareholders' best interests in connection with the sale process to Sun. The transaction may undervalue the Company and will not result in any substantial gain for many DUSA shareholders as DUSA stock traded at $7.00 on October 16, 2012. In addition, an analyst has set a $9.50 per share price target for DUSA. 
 
If you own shares of DUSA stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com by calling toll free 877-LEGAL-90. 

To Join the DUSA Pharmaceuticals, Inc. Litigation

1. Fill out this form

   Mr/Mrs/Ms --Select a title-- Mr. Mrs. Ms.

   First Name: Required

   Last Name:Required

   
   

   Address: Required

   City: Required

   State: Required Select a State AK AL AR AZ CA CO CT DC DE FL GA HI IA ID IL IN KS KY LA MA MD ME MI MN MO MS MT NC ND NE NH NJ NM NV NY OH OK OR PA RI SC SD TN TX UT VA VT WA WI WV WY

   
   

   Email Address:Required

   Phone Number:Required

   
   

   Number of Shares Owned:Required

   Date purchased:

   
   

   By clicking on the submit button, I acknowledge that I have downloaded and read both the Merger Class Action Lawsuit Retainer Agreement and Class Representative Rights and Responsibilities documents, and agree to retain Brodsky & Smith, LLC to file an action against DUSA Pharmaceuticals, Inc. in connection with this case. Brodsky & Smith, LLC will prosecute the action on a contingent fee basis and will advance all costs and expenses.
   

View Complaint

The complaint is unavailable at this time

Join Other Cases

Frequently Asked Questions

 

Home : All cases : Report a Fraud

FAQ's : Attorneys : Practice Areas : Contact Us : Links : Disclaimer